title: Profiling of eicosanoids in inflamed gall bladder wall by gas chromatography with selected-ion monitoring.
abstract: The profiling of eicosanoids, including prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF2 alpha), 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), thromboxane B2 (TXB2) and leukotriene B4 (LTB4), in dog and human gall bladders was carried out by a combination of an effective and convenient clean-up procedure and gas chromatography with selected-ion monitoring. The clean-up procedure was based on the stepwise elution of their methyl ester derivatives from a silica gel column with n-hexane-ethyl acetate and ethyl acetate-methanol in various ratios. The LTB4 methyl ester was eluted with an n-hexane-ethyl acetate (2:1, v/v) fraction because LTB4 is more lipophilic than the other eicosanoids. The present method permitted the quantitation of trace amounts of eicosanoids, including LTB4, present in tissues in the order of pg/mg of protein, without interference from other endogenous substances. In experimental acalculous cholecystitis produced in dog, the levels of eicosanoids (except LTB4) were significantly changed. Of these eicosanoids, the level of 6-keto-PGF1 alpha was significantly higher in the seromuscular layer and correlated with the observed severe morphological changes. In human chronic cholecystitis with gallstones, the level of 6-keto-PGF1 alpha in the mucosal layer was significantly higher than that in the seromuscular layer. These data suggest that prostaglandin I2 may play an important pathophysiological role in the course of cholecystitis.
authors.affiliation: Department of Surgery I, Kyushu University Faculty of Medicine, Fukuoka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sakurai
authors.forename: H
authors.initials: H
authors.lastname: Ichimiya
authors.forename: H
authors.initials: H
authors.lastname: Miyazaki
authors.forename: F
authors.initials: F
authors.lastname: Nakayama
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000302:isolation & purification / Q000378:metabolism; D000818:Animals; D002764:Cholecystitis / Q000378:metabolism*; D015237:Dinoprost / Q000302:isolation & purification / Q000378:metabolism; D015232:Dinoprostone / Q000302:isolation & purification / Q000378:metabolism; D004285:Dogs; D015777:Eicosanoids / Q000032:analysis* / Q000378:metabolism; D005260:Female; D005704:Gallbladder / Q000737:chemistry* / Q000378:metabolism; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006801:Humans; D007975:Leukotriene B4 / Q000302:isolation & purification / Q000378:metabolism; D008297:Male
chemical_list: D015777:Eicosanoids; D007975:Leukotriene B4; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost; D015232:Dinoprostone